Evidence map›Paper›PMID 25918604›Full record

ArticleRare tumors2015

Paraneoplastic autoimmune hemolytic anemia in ovarian cancer: a marker of disease activity.

Kah Poh Loh, Ankit Kansagra, Armen Asik, Syed Ali, Saurabh Dahiya

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Rare tumors, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Cold Agglutinin Disease in the Setting of Pancreatic Adenocarcinoma.European journal of case reports in internal medicine · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kah Poh LohDivision of General Medicine, Baystate Medical Center/Tufts University School of Medicine , Springfield, MA, USA.
Ankit KansagraDivision of Hematology/Oncology, Department of Medicine, Baystate Medical Center/Tufts University School of Medicine , Springfield, MA, USA.
Armen AsikDivision of Hematology/Oncology, Department of Medicine, Baystate Medical Center/Tufts University School of Medicine , Springfield, MA, USA.
Syed AliDivision of Hematology/Oncology, Department of Medicine, Baystate Medical Center/Tufts University School of Medicine , Springfield, MA, USA.
Saurabh DahiyaDivision of Hematology/Oncology, Department of Medicine, Baystate Medical Center/Tufts University School of Medicine , Springfield, MA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoimmune hemolytic anemia (AIHA) is a rare paraneoplastic syndrome associated with ovarian malignancies. We report a case of a 77 year-old female with metastatic ovarian carcinoma who presented with worsening anemia from her baseline, and was found to have a warm autoimmune hemolytic anemia. We performed a literature review and analyzed all 10 cases (including our patient) that have been reported to date, and incorporated the clinical presentation, histology and stage of underlying malignancies, types, treatment, prognosis and mechanisms of AIHA in ovarian carcinoma.

Indexed as

autoimmune hemolytic anemiaovarian cancerparaneoplastic syndrome

Identifiers

PMID25918604
PMCPMC4387350

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.